Literature DB >> 20350215

Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).

Eva Karamitopoulou1, Inti Zlobec, Luigi Tornillo, Vincenza Carafa, Thomas Schaffner, Thomas Brunner, Markus Borner, Ioannis Diamantis, Arthur Zimmermann, Luigi Terracciano.   

Abstract

AIMS: Pancreatic cancer is an aggressive tumour following a multistep progression model through precursors called pancreatic intraepithelial neoplasia (PanIN). Identification of reliable prognostic markers would help in improving survival. The aim of this study was to investigate the role as well as the prognostic significance of different cell cycle and proliferation markers, namely p21, p27, p53 and Ki-67, in pancreatic carcinogenesis.
METHODS: We analysed the expression of p21, p27, p53 and Ki-67, in 210 ductal pancreatic adenocarcinomas, 40 PanIN-3 cases and 40 normal controls combined in a tissue microarray. The results were correlated with clinicopathological and follow-up data.
RESULTS: Our study revealed a differential p27, p21, p53, and Ki-67 expression between ductal adenocarcinoma, PanIN-3 and normal pancreas. p27 expression progressively decreased from normal pancreas to PanIN and to pancreatic cancer. Decreased p27 and increased p53 expression showed a significant association with the T stage. A Ki-67 >5% correlated with reduced survival.
CONCLUSIONS: In pancreatic cancer, loss of p27 and increased p53 expression is associated with a more aggressive phenotype. p27 may play an important role in pancreatic carcinogenesis. A Ki-67 >5% independently predicted poor outcome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20350215     DOI: 10.3109/00313021003631379

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  10 in total

1.  Skp2 is required for incretin hormone-mediated β-cell proliferation.

Authors:  Shuen-Ing Tschen; Senta Georgia; Sangeeta Dhawan; Anil Bhushan
Journal:  Mol Endocrinol       Date:  2011-10-06

2.  p16, p21, and p53 proteins play an important role in development of pancreatic intraepithelial neoplastic.

Authors:  Justyna Zińczuk; Konrad Zaręba; Katarzyna Guzińska-Ustymowicz; Bogusław Kędra; Andrzej Kemona; Anna Pryczynicz
Journal:  Ir J Med Sci       Date:  2018-02-01       Impact factor: 1.568

3.  MicroRNA-375 and MicroRNA-221: Potential Noncoding RNAs Associated with Antiproliferative Activity of Benzyl Isothiocyanate in Pancreatic Cancer.

Authors:  Aruna Basu; Hansjuerg Alder; Amer Khiyami; Patrick Leahy; Carlo M Croce; Subrata Haldar
Journal:  Genes Cancer       Date:  2011-02

4.  Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model.

Authors:  Silvia D Stan; Shivendra V Singh; David C Whitcomb; Randall E Brand
Journal:  Nutr Cancer       Date:  2013-11-06       Impact factor: 2.900

5.  Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer.

Authors:  K Kaira; Y Sunose; K Arakawa; T Ogawa; N Sunaga; K Shimizu; H Tominaga; N Oriuchi; H Itoh; S Nagamori; Y Kanai; A Segawa; M Furuya; M Mori; T Oyama; I Takeyoshi
Journal:  Br J Cancer       Date:  2012-07-17       Impact factor: 7.640

Review 6.  Proteomic and genomic profiling of pancreatic cancer.

Authors:  Daniel Ansari; William Torén; Qimin Zhou; Dingyuan Hu; Roland Andersson
Journal:  Cell Biol Toxicol       Date:  2019-02-15       Impact factor: 6.691

7.  Role of Maspin, CK17 and Ki-67 Immunophenotyping in Diagnosing of Pancreatic Ductal Adenocarcinoma in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology.

Authors:  Mona M Mamdouh; Hussein Okasha; Hebat Allah M Shaaban; Nesreen H Hafez; Emad Hamza El-Gemeie
Journal:  Asian Pac J Cancer Prev       Date:  2021-10-01

8.  A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.

Authors:  Jordan M Winter; Laura H Tang; David S Klimstra; Murray F Brennan; Jonathan R Brody; Flavio G Rocha; Xiaoyu Jia; Li-Xuan Qin; Michael I D'Angelica; Ronald P DeMatteo; Yuman Fong; William R Jarnagin; Eileen M O'Reilly; Peter J Allen
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

Review 9.  The roles of FOXM1 in pancreatic stem cells and carcinogenesis.

Authors:  Ming Quan; Peipei Wang; Jiujie Cui; Yong Gao; Keping Xie
Journal:  Mol Cancer       Date:  2013-12-10       Impact factor: 27.401

10.  Expression of chosen cell cycle and proliferation markers in pancreatic intraepithelial neoplasia.

Authors:  Justyna Zińczuk; Konrad Zaręba; Katarzyna Guzińska-Ustymowicz; Bogusław Kędra; Andrzej Kemona; Anna Pryczynicz
Journal:  Prz Gastroenterol       Date:  2018-05-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.